Featured Content
Advances in the Biologic Role of HER2
Chapter 3: Drs. O’Shaughnessy and colleagues discuss the most exciting advances in the biologic role of HER2 in metastatic breast cancer.
Breast Density and Risk Factors Indicate Breast Cancer Screening Intervals
Authors of a modeling study recommend triennial mammography for 12% of women aged 50 years, and 20% aged 65 years with low breast density and ...
Poor Sleep Quality Associated With Symptom Burden Among Phase 1 Trial Participants
Patients who slept poorly exhibited greater symptom burden and overall mood disturbance.
PAP Series: Patient Assistance Programs "Culprits" of Rising Drug Prices
The federal government is investigating some drugmakers' relationships with the charities that run assistance programs.
Gene-expression Prognostic Signatures Guide Adjuvant Chemotherapy of Early-stage Breast Cancer
Gene expression prognostic signatures continue to evolve to provide greater accuracy for both short- and long-term risk of recurrence.Breast Cancer News
Breast Cancer Resources
More Breast Cancer Information
Caregiving for Your Loved One With Triple Negative Breast Cancer
August 11, 2016
Caregiving for your loved one with triple negative breast cancer may feel like a full time job.
How to Communicate Metastatic Breast Cancer Pain
July 24, 2014
This fact sheet educates patients on how to properly describe the details of their metastatic breast cancer pain to their oncologist.
Molecular Profiling: Personalizing Breast Cancer Treatment
October 30, 2013
This patient information fact sheet reviews how doctors use molecular profiling to offer patients more targeted therapy options.
BRCA1 and BRCA2: Cancer Risk and Genetic Testing
October 07, 2013
This fact sheet provides information about the BRCA1 and BRCA2 genes and related genetic testing.
Can Antiperspirants/Deodorants Cause Breast Cancer?
August 21, 2013
This fact sheet discusses evidence behind if antiperspirants and deodorants may be linked to breast cancer.
The Treatment Landscape of Breast Cancer
The treatment landscape in breast cancer has evolved dramatically within the past several decades.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Prostate Cancer | Regimens | Drugs |
| Rare Cancers | Regimens | |
| Renal Cell Carcinoma | Regimens | Drugs |
| Skin Cancer | Regimens | Drugs |
| Urologic Cancers | Regimens | Drugs |
Cancer Therapy Advisor Articles
- Combined Treatment May Lead to Cure for Chronic Myeloid Leukemia
- The Next Frontier: Radiotherapy Plus Immunotherapy for Melanoma Brain Metastases
- Emerging Prognostic Markers Continue to Improve Myeloma Treatment
- Risk of Arrhythmias, Bleeding Higher With Ibrutinib Therapy
- Metastasis More than Doubles With Monitoring Instead of Treatment for Localized Prostate Cancer
- Adding CVP ± Rituximab After IFRT Improves PFS vs IFRT Alone in Stage 1-2 Follicular Lymphoma
- ASTRO: Study Affirms Efficacy of Doxepin Rise for Treatment of Oral Mucositis Pain
- Lenalidomide Maintenance Recommended in Myeloma Post-transplant
- Calcifications Linked With Favorable, Unfavorable Prognostic Factors in Breast Cancer
- Height and Melanoma Risk: What's the Takeaway?
